University of Arizona

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Arizona sits in the top decile of US sponsors by registered trial count (#101 of 15,742 sponsors by registered trial count).

349 total trials 56 currently recruiting 213 completed early-phase tilt top decile by trial count

University of Arizona: 349 sponsored US clinical trials, 56 recruiting.

University of Arizona sponsors 349 registered US clinical trials on ClinicalTrials.gov, 56 of them currently recruiting, and 213 completed. 21 of these trials are in Phase 3-4 (later-stage) and 100 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 6 trials.

Top-decile sponsor footprint

University of Arizona ranks in the top decile of sponsors by registered trial count (#101 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 44/100

213 of 260 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

349 total, page 2 of 7

RECRUITING Phase 3

Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH

NCT04062565

RECRUITING Early Phase 1

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

NCT06643221

RECRUITING Phase 1

Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia

NCT03781115

RECRUITING

Pharmacogenomics of Warfarin in Hispanics and Latinos

NCT02972385

RECRUITING

Pharmacogenomics of Heparin-Induced Thrombocytopenia

NCT02717039

RECRUITING

Arizona Cancer Center Biospecimen Repository

NCT00896935

ACTIVE NOT RECRUITING Phase 1

Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks

NCT07099222

ACTIVE NOT RECRUITING Phase 2

Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients

NCT05699603

ACTIVE NOT RECRUITING NA

Training Grammar With Meaning

NCT06250101

ACTIVE NOT RECRUITING NA

Fitbit Device Use in Overweight Pregnancy

NCT06226597

ACTIVE NOT RECRUITING NA

Hispanic Adapted and Culturally Relevant Exercising Together

NCT06018311

ACTIVE NOT RECRUITING NA

Multi-site, Longitudinal Trial Evaluating the Efficacy, Mechanisms, and Moderators of Service Dogs for Military Veterans With PTSD

NCT05900479

ACTIVE NOT RECRUITING NA

Firefighter Collaborative Research Project

NCT05869747

ACTIVE NOT RECRUITING Phase 1

Altering Default Mode Network Activity With Transcranial Focused Ultrasound to Reduce Depressive Symptoms

NCT06320028

ACTIVE NOT RECRUITING Phase 2

Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia

NCT05237960

ACTIVE NOT RECRUITING NA

Enfamil NeuroPro Study

NCT06059209

ACTIVE NOT RECRUITING NA

SMLI With Hispanic Cancer Survivors and Caregivers

NCT05364372

ACTIVE NOT RECRUITING NA

Green Light Exposure in Healthy Volunteers Exposure in Normal Human Volunteers

NCT05295225

ACTIVE NOT RECRUITING Phase 2

Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer

NCT04820179

ACTIVE NOT RECRUITING NA

Improving Sleep in Gynecologic Cancer Survivors

NCT05044975

ACTIVE NOT RECRUITING NA

Breathing Training for Improving Cardiovascular Health in Older Adults With Sleep Apnea

NCT04932447

ACTIVE NOT RECRUITING NA

Spectacle Prescribing in Early Childhood

NCT04728451

ACTIVE NOT RECRUITING NA

Exercise and COVID-19 Viral T-cell Immunity

NCT05019456

ACTIVE NOT RECRUITING NA

Early vs Delayed Weightbearing After Surgical Fixation of Unstable Ankle Fractures With Syndesmosis Disruption

NCT05587842

ACTIVE NOT RECRUITING

An Extended Follow-Up Study of the HPV Vaccine Delayed Booster Trial

NCT04688476

ACTIVE NOT RECRUITING NA

Improving Voice Production for Adults With Age-related Dysphonia

NCT03702322

ACTIVE NOT RECRUITING NA

The Effect of Light Therapy on Post-Surgical Pain

NCT03674697

ACTIVE NOT RECRUITING NA

Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders

NCT03540745

ACTIVE NOT RECRUITING NA

The Effect of Light Therapy on Chronic Pain

NCT03677206

NOT YET RECRUITING NA

Elucidating the Central Mechanisms of Action for Green Light Therapy in Managing Chronic Pain

NCT05569486

NOT YET RECRUITING NA

Human Papillomavirus (HPV) Self-Sampling Options to Promote Equity

NCT07214506

NOT YET RECRUITING NA

Progressive Muscle Relaxation Delivered Via Virtual Reality - an Intervention for Patients Undergoing Cellular Therapy

NCT07649512

NOT YET RECRUITING Early Phase 1

GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

NCT07627191

NOT YET RECRUITING Phase 1

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

NCT07254793

NOT YET RECRUITING NA

Methadone Patient Access to Collaborative Treatment

NCT06556602

NOT YET RECRUITING Phase 2

NAC-REPAIR for Post-surgical Pain

NCT07227649

NOT YET RECRUITING NA

Circadian Light Exposure Adjustment for Restfulness

NCT07391852

COMPLETED NA

The Clinical Application of Apple AirPods Pro 2 vs. Hearing Aids

NCT07044518

COMPLETED NA

Pilot Study of App-delivered Sleep Coaching Among Cancer Survivors and Their Partners

NCT06938802

COMPLETED NA

Impact of Osteopathic Manipulative Medicine on Sentinal Lymph Node Biopsy Dye and Tracer Uptake

NCT07269860

NOT YET RECRUITING NA

Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial

NCT06931821

COMPLETED NA

Pilot Study of Methadone Patient Access to Collaborative Treatment: a HEAL Initiative

NCT06513728

COMPLETED NA

Eat, Play, Sleep: A Text Message Approach to Promoting Health Behaviors for Cancer Survivors and Their Caregivers

NCT06234267

COMPLETED NA

A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men

NCT04186260

COMPLETED NA

Diabetes Self-Management Plus Tai Chi Easy

NCT06180655

COMPLETED NA

Digital Connections: an EHealth Group Intervention for Young Adult Cancer Survivors

NCT05952492

COMPLETED NA

Multiple Myeloma Yoga Pilot Study

NCT06061302

COMPLETED NA

A Shared Medical Appointment Intervention for Quality of Life Improvement in POTS

NCT05454137

NOT YET RECRUITING

CT-guided Pudendal Nerve Cryoneurolysis for Palliation of Malignancy-induced Pelvic Pain

NCT06110065

COMPLETED NA

Investigations of Ear Tip Performance, Perceptions, and Experiences

NCT05725824

← Previous Page 2 of 7 Next →

Phase Distribution

PhaseTrial count
Phase 1 43
Phase 2 57
Phase 3 8
Phase 4 13

What is open in the University of Arizona pipeline

56 recruiting of 349 indexed (16% open); 213 completed (61%).

Phase mix: 21 late (III/IV) vs 100 early (I/II) (early-phase heavy).

Top condition: Breast Cancer (6 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Arizona: open-pipeline peers nationwide

Peers matched on 349 registered trials and 16% open enrollment, not the therapeutic-area sidebar.

University of Arizona sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20%25% Total trials Recruiting share University of ArizonaMontefiore Medical CenterNational Institute of Mental Health (NIMH)Children's Oncology GroupOhio State University Comprehensive Cancer CenterECOG-ACRIN Cancer Research GroupGeorge Mason UniversityUniversity of California, San FranciscoNational Human Genome Research Institute (NHGRI)
University of Arizona sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Arizona sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 349 trials (± recruiting share)

Sponsors near 16% open enrollment (± trial volume)

What to do with this University of Arizona page

349 registered trials is a research-attention snapshot, not an endorsement of University of Arizona or any single study.

  • 56 of University of Arizona's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Breast Cancer is the condition University of Arizona studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Arizona pipeline card: 349 registered trials from official public datasets.Report a data error.